Skip to content
OpenCapital
Get started

Ducommun DCO Cumulative Gross Losses and Impairments

Cumulative Gross Losses and Impairments at other companies

Howmet Aerospace logo
Howmet AerospaceHWM
$725M0.0%

Other financials

Income statement

See full
Revenue$209.0M+8.6%
Gross profit$56.2M+11.5%
Operating income$15.7M+216%
Net income$9.9M+607%
EPS (diluted)$0.64+611%

Balance sheet

See full
Cash & equivalents$39.1M+27.2%
Total debt$343.8M+26.9%
Total equity$669.8M-3.2%
Total assets$1.2B+5.1%

Cash flow

See full
Operating cash flow$11.2M+1,358%
CapEx$2.9M-39.0%
Free cash flow$8.3M+305%

Valuation

See full
Market cap$2.45B+112%
Enterprise value$2.75B+93.4%
P/S2.9×+1.4×

Profitability

See full
Gross margin27%+1.5pp
Operating margin-3%-7.4pp
Net margin-3.4%-5.6pp
FCF margin-4.3%-7.2pp

Returns & leverage

See full
Return on equity-4.2%-6.7pp
Debt / equity0.5×+0.1×
Current ratio3.7×+0.3×

Where this comes from

Reported directly by Ducommun in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.

The official record: Ducommun’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ducommun's cumulative gross losses and impairments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ducommun's cumulative gross losses and impairments?
Ducommun (DCO) reported cumulative gross losses and impairments of $81.72M in Q4 2025.
How has Ducommun's cumulative gross losses and impairments changed year-over-year?
Ducommun's cumulative gross losses and impairments decreased by 0.0% year-over-year, from $81.72M to $81.72M.
What is the long-term trend for Ducommun's cumulative gross losses and impairments?
Over 5 years (2020 to 2025), Ducommun's cumulative gross losses and impairments has grown at a 0.0% compound annual growth rate (CAGR), from $81.72M to $81.72M.
What does cumulative gross losses and impairments mean?
This metric aggregates all unrealized losses and recognized impairment charges on investment securities that have not yet been realized through a sale. It provides a comprehensive view of the negative valuation adjustments impacting the bank's equity. It is a key indicator of the credit and market risk embedded in the bank's long-term holdings.